Case Study: Altis Biologics: From Labs to Riches?

Title
Altis Biologics: From Labs to Riches?  

Author
Alison Gaylard; Boris Urban 

Pages
17 

Product Type
Case 

Reference #
WBS-2009-15 

Teaching Note
 

Institute

Setting
Johannesburg 

Year
2009 

Keywords
Entrepreneurship, innovation technology & entrepreneurship, medical technology.



Summary/
Abstract
Doctor Nicolaas Duneas was in a quandary: as he sat in his dishevelled office at the Tshwane University of Technology (TUT), he pondered the future of his company Altis Biologics. Founded in 2002, Altis was a small biotechnology company specialising in bone regeneration. Duneas was a trusted expert in his field, and Altis represented his life’s work. Now, in July 2009, the company was poised in a kind of no-man’s land. Duneas still needed to complete one more set of clinical trials before he could take his product to market, and for that he needed significant capital. Feeling like a very small fish in the big pond of global pharmaceuticals, Duneas wondered just how he was going to find the right funding and strategic partners to expand his business. Was he right to launch his product locally first? And was he being too ambitious by setting his sights on the overseas market

 


 

 

 

AABS Insight Newsletter

AABS Insight is the Association's quarterly newsletter.

Sign Up Here

AABS Case Studies

Over 300 African case studies are listed in the AABS case study database.

Submit a Case Study Here

View a Case Study Here